Literature DB >> 12748030

Psychiatric symptoms, impaired function, and medical care costs in an HMO setting.

Enid M Hunkeler1, William D Spector, Bruce Fireman, Dorothy P Rice, Constance Weisner.   

Abstract

More information is needed regarding the medical care utilization and costs of individuals who report depressed mood, persistent anxiety, brief anxiety, panic, and trouble controlling violent behavior. We present findings from a 1-year prospective follow-up study of a stratified random sample of adult HMO enrollees (N = 10,377) originally interviewed by telephone. A strong association was observed between these psychiatric symptoms, associated impaired function, and general medical care costs during the year following the interview. After controlling for age, gender, race, medical conditions, and smoking, the mean costs of general medical care were $1,948 for respondents who reported none of the psychiatric symptoms or impaired function: $3,006 for respondents with all 5 symptoms but no impaired function; and $3,906 for those with all 5 symptoms and pervasive functional impairment. Persistent anxiety and depressed mood had the greatest impact on total general medical costs, while impaired function was associated with increased likelihood of hospital admission and emergency room use. We conclude that depressed mood, persistent anxiety, and related impaired function are associated with substantial increases in the use and cost of general medical care.

Entities:  

Mesh:

Year:  2003        PMID: 12748030     DOI: 10.1016/s0163-8343(03)00018-5

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  7 in total

1.  Medical problems among adolescents in U.S. mental health services: relationship to functional impairment.

Authors:  Lynn A Warner
Journal:  J Behav Health Serv Res       Date:  2006-07       Impact factor: 1.505

2.  General medical and pharmacy claims expenditures in users of behavioral health services.

Authors:  Roger G Kathol; Donna McAlpine; Yasuhiro Kishi; Robert Spies; William Meller; Terence Bernhardt; Steven Eisenberg; Keith Folkert; William Gold
Journal:  J Gen Intern Med       Date:  2005-02       Impact factor: 5.128

3.  The impact of DSM-IV symptom and clinical significance criteria on the prevalence estimates of subthreshold and threshold anxiety in the older adult population.

Authors:  Sébastien Grenier; Michel Préville; Richard Boyer; Kieron O'Connor; Sarah-Gabrielle Béland; Olivier Potvin; Carol Hudon; Joëlle Brassard
Journal:  Am J Geriatr Psychiatry       Date:  2011-04       Impact factor: 4.105

4.  Symptoms of depression in a Hispanic primary care population with and without chronic medical illnesses.

Authors:  Jenny Chong; Kerstin M Reinschmidt; Francisco A Moreno
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

5.  Depression and comorbid illness in elderly primary care patients: impact on multiple domains of health status and well-being.

Authors:  Polly Hitchcock Noël; John W Williams; Jürgen Unützer; Jason Worchel; Shuko Lee; John Cornell; Wayne Katon; Linda H Harpole; Enid Hunkeler
Journal:  Ann Fam Med       Date:  2004 Nov-Dec       Impact factor: 5.166

6.  Brief behavioral treatment for insomnia in older adults with late-life treatment-resistant depression and insomnia: a pilot study.

Authors:  Marie Anne Gebara; Elizabeth A DiNapoli; Lisa G Lederer; Adam D Bramoweth; Anne Germain; John W Kasckow; Jordan F Karp
Journal:  Sleep Biol Rhythms       Date:  2019-01-28       Impact factor: 1.186

7.  Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

Authors:  Christopher M Blanchette; Linda Simoni-Wastila; Fadia T Shaya; Denise Orwig; Jason Noel; Bruce Stuart
Journal:  Cardiol Res Pract       Date:  2009-12-22       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.